Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maerevoet

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Revue Medicale De Bruxelles|February 14, 2015
[Anemia in the elderly]M Maerevoet, L Sattar, D Bron, et al.
Revue Medicale De Bruxelles|January 12, 2016
[Hemolytic anemia and dysenteric syndrome: a case of ulcerative colitis]G Claes, M Colard, F S Benghiat, et al.
Leukemia|June 1, 1995
Cyclosporin A in the treatment of refractory B chronic lymphocytic leukemia (B-CLL)E Van Den Neste, M Maerevoet, P Martiat, et al.
Leukemia & Lymphoma|May 1, 1996
Limited activity of mini-dose interferon alpha-2a in the treatment of myelodysplastic syndromeM Maerevoet, E Van Den Neste, A Delannoy, et al.
Leukemia & Lymphoma|August 26, 1998
Myeloid and lymphoid recovery following allogeneic bone marrow transplantation: a comparative study between related, unrelated bone marrow and allogeneic peripheral stem cell transplantationR Trenschel, M Bernier, A Delforge, et al.
La Revue De Medecine Interne|July 5, 2017
[Weight loss, fever and arthralgia in a 43-year-old man treated for follicular lymphoma]M Vandeputte, B Couturier, F Vandergheynst, et al.
Revue Medicale De Bruxelles|November 24, 2015
[Practical approach of lymphomas: major role of general practitioner who has to face all these emerging drugs]D Bron, R Dewind, B Cantinieaux, et al.
Leukemia|October 29, 2004
Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in "unmutated" B-CLLL Michaux, I Wlodarska, K Rack, et al.
Leukemia|February 20, 2004
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemiasP Vandenberghe, I Wlodarska, L Michaux, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 30, 2020
Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphomaG Manson, P Brice, C Herbaux, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Revue Medicale De Bruxelles|February 14, 2015
[Anemia in the elderly]M Maerevoet, L Sattar, D Bron, et al.
Revue Medicale De Bruxelles|January 12, 2016
[Hemolytic anemia and dysenteric syndrome: a case of ulcerative colitis]G Claes, M Colard, F S Benghiat, et al.
Leukemia|June 1, 1995
Cyclosporin A in the treatment of refractory B chronic lymphocytic leukemia (B-CLL)E Van Den Neste, M Maerevoet, P Martiat, et al.
Leukemia & Lymphoma|May 1, 1996
Limited activity of mini-dose interferon alpha-2a in the treatment of myelodysplastic syndromeM Maerevoet, E Van Den Neste, A Delannoy, et al.
Leukemia & Lymphoma|August 26, 1998
Myeloid and lymphoid recovery following allogeneic bone marrow transplantation: a comparative study between related, unrelated bone marrow and allogeneic peripheral stem cell transplantationR Trenschel, M Bernier, A Delforge, et al.
La Revue De Medecine Interne|July 5, 2017
[Weight loss, fever and arthralgia in a 43-year-old man treated for follicular lymphoma]M Vandeputte, B Couturier, F Vandergheynst, et al.
Revue Medicale De Bruxelles|November 24, 2015
[Practical approach of lymphomas: major role of general practitioner who has to face all these emerging drugs]D Bron, R Dewind, B Cantinieaux, et al.
Leukemia|October 29, 2004
Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in "unmutated" B-CLLL Michaux, I Wlodarska, K Rack, et al.
Leukemia|February 20, 2004
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemiasP Vandenberghe, I Wlodarska, L Michaux, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 30, 2020
Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphomaG Manson, P Brice, C Herbaux, et al.
Pageof 2